The European Commission said on September 19 that it raided a cardiovascular medical device company in an EU country on concerns that it may have abused its market power in breach of the bloc’s antitrust rules, but did not name the company, noted Reuters, which says the antitrust regulators raided Edwards Lifesciences at one of its EU facilities a week ago, citing two people familiar with the matter. Edwards Lifesciences did not respond to emailed requests for comment, Reuters said.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on EW:
- Edwards Lifesciences (EW) Under the Radar of EU Antitrust Regulators
- Early notable gainers among liquid option names on September 26th
- Edwards Lifesciences upgraded to Outperform from Perform at Oppenheimer
- Edwards Lifesciences price target lowered to $83 from $88 at Piper Sandler
- Edwards Lifesciences (NYSE:EW) Q2 Results Leave Analysts Divided; Stock Down 10%